281 related articles for article (PubMed ID: 27681004)
1. Diagnosis of invasive fungal diseases in pediatric patients.
Pana ZD; Vikelouda K; Roilides E
Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1203-1213. PubMed ID: 27681004
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
Zheng F; Zha H; Yang D; Deng J; Zhang Z
Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
[TBL] [Abstract][Full Text] [Related]
4. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases.
Lass-Florl C; Alastruey-Izquierdo A; Gupta R; Chakroborti A
Indian J Med Microbiol; 2022; 40(4):480-484. PubMed ID: 35970627
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases.
Sarwar M; Gardezi SAH; Zaman G; Ikram A; Satti L; Khadim MT
J Pak Med Assoc; 2020 Mar; 70(3):442-446. PubMed ID: 32207422
[TBL] [Abstract][Full Text] [Related]
6. Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.
McCarthy MW; Petraitiene R; Walsh TJ
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538702
[TBL] [Abstract][Full Text] [Related]
7. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
[TBL] [Abstract][Full Text] [Related]
8. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.
Verma N; Singh S; Taneja S; Duseja A; Singh V; Dhiman RK; Chakrabarti A; Chawla YK
Liver Int; 2019 Mar; 39(3):503-513. PubMed ID: 30276951
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
[TBL] [Abstract][Full Text] [Related]
10. Fungal diagnosis: how do we do it and can we do better?
Perfect JR
Curr Med Res Opin; 2013 Apr; 29 Suppl 4():3-11. PubMed ID: 23621588
[TBL] [Abstract][Full Text] [Related]
11. Cell wall polysaccharides from pathogenic fungi for diagnosis of fungal infectious disease.
Ahamefula Osibe D; Lei S; Wang B; Jin C; Fang W
Mycoses; 2020 Jul; 63(7):644-652. PubMed ID: 32401381
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods.
Oz Y; Kiraz N
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):289-98. PubMed ID: 21417868
[TBL] [Abstract][Full Text] [Related]
13. Update on the diagnosis of invasive fungal infection.
Ibáñez-Martínez E; Ruiz-Gaitán A; Pemán-García J
Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():16-21. PubMed ID: 28882009
[TBL] [Abstract][Full Text] [Related]
14. Update on Non-Culture-Based Diagnostics for Invasive Fungal Disease.
Yan G; Chew KL; Chai LYA
Mycopathologia; 2021 Oct; 186(5):575-582. PubMed ID: 34213735
[TBL] [Abstract][Full Text] [Related]
15. Invasive mould infections in the ICU setting: complexities and solutions.
Bassetti M; Bouza E
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of fungal infection: Expert opinion on the current situation.
Bouza E; Almirante B; García Rodríguez J; Garnacho-Montero J; Salavert M; Muñoz P; Sanguinetti M
Rev Esp Quimioter; 2020 Feb; 33(1):1-10. PubMed ID: 31729203
[TBL] [Abstract][Full Text] [Related]
17. Detection of β-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy.
Guitard J; Tabone MD; Senghor Y; Cros C; Moissenet D; Markowicz K; Valin N; Leverger G; Hennequin C
J Infect; 2016 Dec; 73(6):607-615. PubMed ID: 27452196
[TBL] [Abstract][Full Text] [Related]
18. [Invasive fungal infections in children: similarities and differences with adults].
Ramos JT; Francisco L; Daoud Z
Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():59-65. PubMed ID: 27608317
[TBL] [Abstract][Full Text] [Related]
19. Early diagnosis of invasive mould infections and disease.
Lamoth F; Calandra T
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i19-i28. PubMed ID: 28355464
[TBL] [Abstract][Full Text] [Related]
20. The Diagnostic Value of (1 → 3)-Beta-D-glucans and Galactomannan Assays in Children Suffering from Bacteremia in Pediatric Intensive Care Unit.
Zheng F; Gu Y; Zha H; Deng J; Zhang Z
Mycopathologia; 2017 Jun; 182(5-6):555-560. PubMed ID: 27928649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
